Metraipolis › archive › dc_2fcedf5c9846

Prostate-specific antigen velocity as a predictor of survival outcomes in patients with prostate cancer: a meta-analysis — Europe PMC PMID:41743950

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41743950
DOI
10.3389/fonc.2026.1656688
License (as archived)
solo-consultazione
Archived
2026-11-05T23:36:28.039Z
SHA-256 of the archived text
b73330eeb0f6516c93b98d7ba80933095e15d87ee544bb884a9a0eb4d50cbbfe
Stable URL of this page
https://metraipolis.com/documento/dc_2fcedf5c9846

How to cite

Prostate-specific antigen velocity as a predictor of survival outcomes in patients with prostate cancer: a meta-analysis — Europe PMC PMID:41743950 — Europe PMC (en), https://europepmc.org/article/MED/41743950 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2fcedf5c9846 (Metraipolis archive dc_2fcedf5c9846, sha256 b73330eeb0f6516c93b98d7ba80933095e15d87ee544bb884a9a0eb4d50cbbfe)
BibTeX
@misc{dc2fcedf5c9846,
  title = {Prostate-specific antigen velocity as a predictor of survival outcomes in patients with prostate cancer: a meta-analysis — Europe PMC PMID:41743950},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41743950},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2fcedf5c9846; sha256 b73330eeb0f6516c93b98d7ba80933095e15d87ee544bb884a9a0eb4d50cbbfe},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41743950. Agents can read the archived copy with the MCP tool read_document.